NEO-STIM

Welcome to the Brand page for “NEO-STIM”, which is offered here for Pharmaceuticals, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids;.

Its status is currently believed to be active. Its class is unavailable. “NEO-STIM” is believed to be currently owned by “BioNTech US Inc.”


Owner:
BIONTECH US INC.
Owner Details
Description:
Pharmaceuticals, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids;
Categories: PHARMACEUTICALS